BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin CC, Huang TL. Lorazepam-diazepam protocol for catatonia in schizophrenia: a 21-case analysis. Compr Psychiatry 2013;54:1210-4. [PMID: 23856388 DOI: 10.1016/j.comppsych.2013.06.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Tseng WT, Huang TL. Excited catatonia in a patient with fatal pulmonary embolism and a successful treatment strategy. BMC Psychiatry 2018;18:342. [PMID: 30340477 DOI: 10.1186/s12888-018-1925-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
2 Chung YJ, Lee SJ. Case report of neuroleptic malignant syndrome with prolonged mental changes and severe dyskinesia. Asia Pac Psychiatry 2018;10. [PMID: 29464897 DOI: 10.1111/appy.12303] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Verma K, Jayadeva V, Serrano R, Sivashanker K. Diagnostic, Treatment, and System Challenges in the Management of Recurrent Neuroleptic Malignant Syndrome on a General Medical Service. Case Rep Psychiatry 2018;2018:4016087. [PMID: 29992074 DOI: 10.1155/2018/4016087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Lin CC, Hung YY, Tsai MC, Huang TL. Relapses and recurrences of catatonia: 30-case analysis and literature review. Compr Psychiatry 2016;66:157-65. [PMID: 26995249 DOI: 10.1016/j.comppsych.2016.01.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
5 Wijemanne S, Jankovic J. Movement disorders in catatonia. J Neurol Neurosurg Psychiatry 2015;86:825-32. [DOI: 10.1136/jnnp-2014-309098] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
6 Yoshimura B, Hirota T, Takaki M, Kishi Y. Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? A case series of 39 patients. Neuropsychiatr Dis Treat 2013;9:1565-71. [PMID: 24143105 DOI: 10.2147/NDT.S52311] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
7 Hirjak D, Sartorius A, Kubera KM, Wolf RC. [Antipsychotic-induced motor symptoms in schizophrenic psychoses-Part 2 : Catatonic symptoms and neuroleptic malignant syndrome]. Nervenarzt 2019;90:12-24. [PMID: 30128733 DOI: 10.1007/s00115-018-0581-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Pelzer AC, van der Heijden FM, den Boer E. Systematic review of catatonia treatment. Neuropsychiatr Dis Treat 2018;14:317-26. [PMID: 29398916 DOI: 10.2147/NDT.S147897] [Cited by in Crossref: 34] [Cited by in F6Publishing: 6] [Article Influence: 8.5] [Reference Citation Analysis]
9 Matias DF, Ando Sde M, Riera R, Góis AF. Malignant catatonia responsive to low doses of lorazepam: case report. Sao Paulo Med J 2016;134:176-9. [PMID: 26465814 DOI: 10.1590/1516-3180.2014.00052608] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Sienaert P, van Harten P, Rhebergen D. The psychopharmacology of catatonia, neuroleptic malignant syndrome, akathisia, tardive dyskinesia, and dystonia. Handb Clin Neurol 2019;165:415-28. [PMID: 31727227 DOI: 10.1016/B978-0-444-64012-3.00025-3] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Chiou YJ, Lee Y, Lin CC, Huang TL. A Case Report of Catatonia and Neuroleptic Malignant Syndrome With Multiple Treatment Modalities: Short Communication and Literature Review. Medicine (Baltimore) 2015;94:e1752. [PMID: 26512569 DOI: 10.1097/MD.0000000000001752] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
12 Lin CC, Hung YY, Tsai MC, Huang TL. The Lorazepam and Diazepam Protocol for Catatonia Due to General Medical Condition and Substance in Liaison Psychiatry. PLoS One 2017;12:e0170452. [PMID: 28114315 DOI: 10.1371/journal.pone.0170452] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
13 Lin CC, Hung YY, Tsai MC, Huang TL. Increased serum anti-N-methyl-D-aspartate receptor antibody immunofluorescence in psychiatric patients with past catatonia. PLoS One. 2017;12:e0187156. [PMID: 29073246 DOI: 10.1371/journal.pone.0187156] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ali SF, Gowda GS, Jaisoorya TS, Math SB. Resurgence of catatonia following tapering or stoppage of lorazepam - A case series and implications. Asian J Psychiatr 2017;28:102-5. [PMID: 28784360 DOI: 10.1016/j.ajp.2017.04.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
15 Roy K, Warnick SJ, Balon R. Catatonia Delirium: 3 Cases Treated With Memantine. Psychosomatics 2016;57:645-50. [DOI: 10.1016/j.psym.2016.08.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
16 Ellul P, Choucha W. Neurobiological Approach of Catatonia and Treatment Perspectives. Front Psychiatry 2015;6:182. [PMID: 26733892 DOI: 10.3389/fpsyt.2015.00182] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
17 Lucas GL, Adewumi AD. A case of quetiapine-induced catatonia. J Pharm Pract Res 2018;48:167-9. [DOI: 10.1002/jppr.1324] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
18 Bai Y, Yang X, Zeng Z, Yang H. A case report of schizoaffective disorder with ritualistic behaviors and catatonic stupor: successful treatment by risperidone and modified electroconvulsive therapy. BMC Psychiatry 2018;18:67. [PMID: 29534691 DOI: 10.1186/s12888-018-1655-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Walther S, Strik W. Catatonia. CNS Spectr 2016;21:341-8. [PMID: 27255726 DOI: 10.1017/S1092852916000274] [Cited by in Crossref: 37] [Cited by in F6Publishing: 13] [Article Influence: 6.2] [Reference Citation Analysis]